We investigated the effect of pre- “race” ingestion of a 1,3-butanediol acetoacetate diester on blood ketone concentration, substrate metabolism and performance of a cycling time trial (TT) in professional cyclists. In a randomized cross-over design, 10 elite male cyclists completed a ~31 km laboratory-based TT on a cycling ergometer programmed to simulate the 2017 World Road Cycling Championships course. Cyclists consumed a standardized meal [2 g/kg body mass (BM) carbohydrate (CHO)] the evening prior to a trial day and a CHO breakfast (2 g/kg BM CHO) with 200 mg caffeine on the morning of a trial day. Cyclists were randomized to consume either the ketone diester (2 × 250 mg/kg) or a placebo drink, followed immediately by 200 mL diet cola, given ~ 30 min before and immediately prior to commencing a 20 min incremental warm-up. Blood samples were collected prior to and during the warm-up, pre- and post- TT and at regular intervals after the TT. Urine samples were collected pre- and post- warm-up, immediately post TT and 60 min post TT. Pre-exercise ingestion of the diester resulted in a 2 ± 1% impairment in TT performance that was associated with gut discomfort and higher perception of effort. Serum β-hydroxybutyrate, serum acetoacetate, and urine ketone concentrations increased from rest following ketone ingestion and were higher than placebo throughout the trial. Ketone ingestion induces hyperketonemia in elite professional cyclists when in a carbohydrate fed state, and impairs performance of a cycling TT lasting ~50 min.
Measurements of exercise heart rate (HR(ex)), HR recovery (HRR) and HR variability (HRV) are used as indices of training status. However, the day-to-day variability of these indices throughout a competitive soccer period is unknown. On 14 occasions during a 3-week competition camp, 18 under 15 (U15) and 15 under 17 (U17) years soccer players performed a 5-min submaximal run, followed by a seated 5-min recovery period. HR(ex) was determined during the last 30 s of exercise, while HRR and HRV were measured during the first and last 3 min of the post-exercise recovery period, respectively. U15 players displayed greater HR(ex) (P = 0.02) and HRR (P = 0.004) compared with the U17 players, but there was no difference in HRV (P = 0.74). The mean coefficient of variation (CV) for HR(ex) was lower than that for HRV [3.4 (90% CL, 3.1, 3.7) vs. 10.7 (9.6, 11.9)%, P < 0.001]; both were lower than that for HRR [13.3 (12.2, 14.3)%, P < 0.01]. In contrast to HR(ex) and HRR, the CV for HRV was correlated to maximal aerobic speed (r = -0.52, P = 0.002). There was no correlation between total activity time (training sessions + matches) and CV of any of the quantified variables. The variability of each of these measures and player fitness levels should be considered when interpreting changes in training status.
To determine the time course of hemoglobin mass (Hb(mass)) to natural altitude training, Hb(mass), erythropoietin [EPO], reticulocytes, ferritin and soluble transferrin receptor (sTfR) were measured in 13 elite cyclists during, and 10 days after, 3 weeks of sea level (n=5) or altitude (n=8, 2760 m) training. Mean Hb(mass), with a typical error of ∼2%, increased during the first 11 days at altitude (mean ± standard deviation 2.9 ± 2.0%) and was 3.5 ± 2.5% higher than baseline after 19 days. [EPO] increased 64.2 ± 18.8% after 2 nights at altitude but was not different from baseline after 12 nights. Hb(mass) and [EPO] did not increase in sea level. Reticulocytes (%) were slightly elevated in altitude at Days 5 and 12 (18.9 ± 17.7% and 20.4 ± 25.3%), sTfR was elevated at Day 12 (18.9 ± 15.0%), but both returned to baseline by Day 20. Hb(mass) and [EPO] decreased on descent to sea level while ferritin increased. The mean increase in Hb(mass) observed after 11 days (∼300 h) of altitude training was beyond the measurement error and consitent with the mean increase after 300 h of simulated live high:train low altitude. Our results suggest that in elite cyclists, Hb(mass) increases progressively with 3 weeks of natural altitude exposure, with greater increases expected as exposure persists.
Background: Numerous laboratory based studies have documented that aggressive hydration strategies (,1-2 litres/h) are required to minimise a rise in core temperature and minimise the deleterious effects of hyperthermia on performance. However, field data on the relations between hydration level, core body temperature, and performance are rare. Objective: To measure core temperature (T core ) in triathletes during a 226 km Ironman triathlon, and to compare T core with markers of hydration status after the event.
Laboratory tests of fitness variables have previously been shown to be valid predictors of cycling time-trial performance. However, due to the influence of drafting, tactics and the variability of power output in mass-start road races, comparisons between laboratory tests and competition performance are limited. The purpose of this study was to compare the power produced in the laboratory Power Profile (PP) test and Maximum Mean Power (MMP) analysis of competition data. Ten male cyclists (mean+/-SD: 20.8+/-1.5 y, 67.3+/-5.5 kg, V O (2 max) 72.7+/-5.1 mL x kg (-1) x min (-1)) completed a PP test within 14 days of competing in a series of road races. No differences were found between PP results and MMP analysis of competition data for durations of 60-600 s, total work or estimates of critical power and the fixed amount of work that can be completed above critical power (W'). Self-selected cadence was 15+/-7 rpm higher in the lab. These results indicate that the PP test is an ecologically valid assessment of power producing capacity over cycling specific durations. In combination with MMP analysis, this may be a useful tool for quantifying elements of cycling specific performance in competitive cyclists.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.